
Julio Agguire-Ghiso, PhD
Director, Institute for Cancer Dormancy and Tumor Microenvironment, Albert Einstein College of Medicine, New York, USA

Emmanuel Antonarakis, MD
Associate Director for Translational Research and Director of Genitourinary Oncology in HOT Division, University of Minnesota–Masonic Cancer Center, USA

Valsamo Anagnostou, MD, PhD
Associate Professor, Medical Oncology, Leader, Precision Oncology Analytics, Director, Thoracic Oncology Biorepository, Co-director, Thoracic Oncology Precision Medicine Center of Excellence, Upper Aerodigestive Oncology Program, Co-leader, Molecular Tumor Board, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, USA

Thomas Carell, MD
Professor, Center for Nucleic Acid Therapies at the Department of Chemistry, Institute for Chemical Epigenetics, Ludwig-Maximilians-Universität München, München, Germany

Ryan Corcoran, MD
Assoc. Professor, Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, Massachusetts

Richard J. Cote, M.D. FRCPath, FCAP
Professor and Incoming Chair, Department of Pathology and Immunology, Pathologist-in-Chief, Barnes-Jewish Hospital, Washinghton University in St Louis, St Louis, USA

Massimo Cristofanilli, MD, FACP
Chief, Breast Medical Oncology
Associate Director of Precision Medicine, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
Scientific Director, the Englander Institute of Precision Medicine, Co-Leader, Meyer Cancer Center Management Team
Associate Director of Precision Medicine, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
Scientific Director, the Englander Institute of Precision Medicine, Co-Leader, Meyer Cancer Center Management Team

Johann de Bono,
Professor, Head of the Division of Clinical Studies, The Institute for Cancer Research, (ICR) and Royal Marsden, London, UK

Caroline Dive, PhD
Professor, Deputy Director Cancer Research UK Manchester Institute, Senior Group Leader Clinical & Experimental Pharmacology, The University of Manchester, UK

Ellen Heitzer, PhD
Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria

Michail Ignatiadis, MD, PhD
Director, Breast Medical Oncology Clinic & Program, Medical Oncology
Department, Institut Bordet, Associate Professor, Université Libre de
Bruxelles, Chair,
Breast Cancer Group, EORTC, Belgium

Pashtoon Murtaza Kasi, M.D., M.S.
Medical Director of GI Medical Oncology; Associate
Clinical Professor, Department of Medical Oncology & Therapeutics Research,
City of Hope, Orange County, California

Peter Kuhn, PhD
Dean’s Professor of Biological
Sciences and Professor of Medicine, Biomedical Engineering, Aerospace &
Mechanical Engineering, and Urology, USC
Michelson CSI-Cancer, Los Angeles, California, USA

Evi Lianidou, PhD
Professor of Analytical Chemistry – Clinical Chemistry, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece

Rafael López, MD, PhD
Medical Oncology Dept. & Translational Medical Oncology Group, University
Clinical Hospital & Health Research Institute (IDIS); CIBERONC, Santiago
de Compostela University School of Medicine, Santiago de Compostela (Spain)

Mike Makrigiorgos, PhD
Professor and Director, Medical Physics and Biophysics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA

Nicholas Papadopoulos, PhD
Professor of Oncology and Pathology, Director of Translational Genetics, Ludwig Center for Cancer Genetics and Therapeutics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA

Jean-Yves Pierga, MD, PhD
Professor of Medical Oncology, at the Institute Curie and University Paris Descartes, Paris, France

Chamindie Punyadeera, MD, PhD, MBA, Dr.hc.
MD, Griffith University, Griffith Institute for Drug Discovery (GRIDD) and Menzies Health Institute Queensland (MIHQ), Saliva and Liquid Biopsy Translational Laboratory, Queensland, Australia

Christian Rolfo, MD, PhD, MBA, Dr.hc.
Director, Division of Medical Oncology, Associate Director for Early Phase Clinical Trials, Arthur G. James Cancer Hospital and Solove Research
Institute, Ohio State University, Comprehensive Cancer Center, Professor, Department of Medicine Ohio State
University College of Medicine

Nitzan Rosenfeld, MD
Director, Barts Cancer Institute - Α Cancer Research UK Centre of Excellence, London, United Kingdom

Nikolas Stoecklein, MD
Professor, Experimental Surgical Oncology, Heinrich Heine University, Düsseldorf, Germany

Andreas Trumpp, PhD
Head, Division of Stem Cells and Cancer at the German Cancer Research Center (DKFZ), Heidelberg, Germany